Literature DB >> 750224

Neurotoxicity of delta-aminolevulinic acid and porphobilinogen.

C A Pierach, P S Edwards.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 750224     DOI: 10.1016/0014-4886(78)90287-x

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  6 in total

1.  Neuropsychiatric porphyria in patients with refractory epilepsy: report of three cases.

Authors:  A S Winkler; T J Peters; R D C Elwes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

2.  Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria.

Authors:  Makiko Yasuda; Lin Gan; Brenden Chen; Chunli Yu; Jinglan Zhang; Miguel A Gama-Sosa; Daniela D Pollak; Stefanie Berger; John D Phillips; Winfried Edelmann; Robert J Desnick
Journal:  Hum Mol Genet       Date:  2019-06-01       Impact factor: 6.150

Review 3.  The acute hepatic porphyrias.

Authors:  Bruce Wang
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

Review 4.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

5.  Polymorphisms of delta-aminolevulinic acid dehydratase (ALAD) and peptide transporter 2 (PEPT2) genes in children with low-level lead exposure.

Authors:  Christina Sobin; Marisela Gutierrez; Heather Alterio
Journal:  Neurotoxicology       Date:  2009-08-31       Impact factor: 4.294

6.  Light-induced depigmentation in planarians models the pathophysiology of acute porphyrias.

Authors:  Bradford M Stubenhaus; John P Dustin; Emily R Neverett; Megan S Beaudry; Leanna E Nadeau; Ethan Burk-McCoy; Xinwen He; Bret J Pearson; Jason Pellettieri
Journal:  Elife       Date:  2016-05-31       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.